The historical rank and industry rank for Shanghai Jiaoda Onlly Co's ROE % or its related term are showing as below:
SHSE:600530'
s ROE % Range Over the Past 10 Years
Min: -86.23 Med: 0 Max: 11.3
Current: 1.28
During the past 13 years, Shanghai Jiaoda Onlly Co's highest ROE % was 11.30%. The lowest was -86.23%. And the median was 0.00%.
SHSE:600530's ROE % is ranked worse than 65.45% of 935
companies
in the Drug Manufacturers industry
Industry Median: 6
vs SHSE:600530: 1.28
Shanghai Jiaoda Onlly Co (SHSE:600530) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Jiaoda Onlly Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Jiaoda Onlly Co ROE % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shanghai Jiaoda Onlly Co's ROE % distribution charts can be found below:
* The bar in red indicates where Shanghai Jiaoda Onlly Co's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Shanghai Jiaoda Onlly Co (SHSE:600530) has a ROE % of -7.95% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Shanghai Jiaoda Onlly Co and its competitors. According to the industry distribution chart, Shanghai Jiaoda Onlly Co ranks #612 out of 935 companies in the Drug Manufacturers industry, placing it in the top 65.5%.
Is Shanghai Jiaoda Onlly Co's ROE % too high?
Shanghai Jiaoda Onlly Co's current ROE % is -7.95%. Based on the distribution chart, Shanghai Jiaoda Onlly Co ranks #612 out of 935 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Shanghai Jiaoda Onlly Co has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Jiaoda Onlly Co's ROE % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Shanghai Jiaoda Onlly Co ranks #612 out of 935 companies for ROE %. This places Shanghai Jiaoda Onlly Co in the lower half of its industry. The industry median ROE % is 6.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Drug Manufacturers company?
The median ROE % among Drug Manufacturers companies is 6.00, based on 935 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Shanghai Jiaoda Onlly Co and its competitors. For the Drug Manufacturers industry, the median ROE % is 6.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Jiaoda Onlly Co's current ROE % is -7.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Jiaoda Onlly Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Jiaoda Onlly Co (SHSE:600530) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥2.96, compared to a current price of ¥5.33 — trading 80.1% above its estimated fair value. The current ROE % is -7.95%. Shanghai Jiaoda Onlly Co's overall GF Score™ is 38/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Shanghai Jiaoda Onlly Co (SHSE:600530), the current ROE % is -7.95% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Jiaoda Onlly Co (SHSE:600530) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Jiaoda Onlly Co stock appears to be overvalued.
The current stock price of ¥5.33 is trading 80.1% above its estimated GF Value™ of ¥2.96.
GuruFocus considers Shanghai Jiaoda Onlly Co to be Significantly Overvalued.
Key valuation signals for SHSE:600530:
ROE %: -7.95%
GF Value™: ¥2.96 vs. price of ¥5.33 (80.1% above fair value)
No single metric tells the full story. See the SHSE:600530 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Jiaoda Onlly Co Ltd is engaged in producing and distributing healthcare products. The company is also involved in real estate and financial investment. Its main products are biological products and healthcare products.
38GF Score
Get the complete analysis for SHSE:600530
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600530 has been successfully added to your 
